Jensen Anni Ravnsbaek, Nellemann Hanne Marie, Overgaard Jens
Department of Experimental Clinical Oncology, Aarhus University Hospital, Nørrebrogade 44, Building 5, DK-8000 Aarhus C, Denmark.
Radiother Oncol. 2007 Jul;84(1):5-10. doi: 10.1016/j.radonc.2007.04.001. Epub 2007 May 9.
Waiting-time prior to radiotherapy is a well-known problem. This study aims to determine the impact of time on tumor growth in a patient population with squamous-cell carcinoma of the head and neck (SCCHN).
In a consecutive cohort, all patients with both a diagnostic scan and a treatment-planning scan were identified. In total 648 patients were seen, and 414 treated with primary radiotherapy. Ninety-five had two scans and 61 sets were eligible for comparison. Endpoints were change in tumor volume, tumor volume doubling time (TVD) and disease progression measured by TNM-classification and RECIST criteria.
Median interval between eligible scans was 28 (5-95) days. Thirty-eight (62%) had measurable increase in tumor volume, median 46% (6-495%). For all patients TVD was median 99 days, but for the half of patients with fastest growing tumors TVD was 30 days (15-41). Tumor volume increase was significantly correlated to time and histological differentiation. Twelve (20%) developed new lymph-node metastasis and 10 (16%) progressed in TNM-classification. Evaluated by RECIST criteria 18 (30%) patients had progressive disease.
This study shows a negative impact of waiting time in patients with SCCHN. Within an average time of 4 weeks the majority of the patients developed significant signs of tumor progression. It was not possible to define a threshold for acceptable time intervals in order to avoid volume changes, or to define a subgroup that has no negative impact of delay.
放疗前的等待时间是一个众所周知的问题。本研究旨在确定时间对头颈鳞状细胞癌(SCCHN)患者群体中肿瘤生长的影响。
在一个连续队列中,识别出所有同时进行了诊断扫描和治疗计划扫描的患者。总共观察了648例患者,其中414例接受了原发性放疗。95例患者有两次扫描,61组符合比较条件。终点指标包括肿瘤体积变化、肿瘤体积倍增时间(TVD)以及通过TNM分类和RECIST标准衡量的疾病进展。
符合条件的扫描之间的中位间隔时间为28(5 - 95)天。38例(62%)患者的肿瘤体积有可测量的增加,中位增加46%(6 - 495%)。所有患者的TVD中位值为99天,但对于肿瘤生长最快的一半患者,TVD为30天(15 - 41)。肿瘤体积增加与时间和组织学分化显著相关。12例(20%)出现了新的淋巴结转移,10例(16%)在TNM分类中病情进展。根据RECIST标准评估,18例(30%)患者出现疾病进展。
本研究表明等待时间对SCCHN患者有负面影响。在平均4周的时间内,大多数患者出现了肿瘤进展的明显迹象。无法确定一个可接受的时间间隔阈值以避免体积变化,也无法确定一个不受延迟负面影响的亚组。